American Well financials
$13.14−2.23%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $249.3M | $254.4M | $259.0M | $277.2M | $252.8M | $245.3M |
| Gross profit | $132.9M | $99.0M | $94.8M | $116.8M | $104.3M | $88.5M |
| Gross margin | 53.3% | 38.9% | 36.6% | 42.1% | 41.3% | 36.1% |
| Operating income | -$105.3M | -$217.5M | -$692.1M | -$275.9M | -$179.1M | -$227.4M |
| Net income | -$95.7M | -$208.1M | -$675.2M | -$270.4M | -$176.3M | -$224.4M |
| Net margin | −38.4% | −81.8% | −260.6% | −97.6% | −69.8% | −91.5% |
| Diluted EPS | $-5.96 | $-13.88 | $-47.50 | $-19.72 | $-13.80 | $-45.40 |
| EBITDA | -$71.3M | -$184.6M | -$660.6M | -$249.7M | -$163.1M | -$217.3M |
| Operating cash flow | -$66.0M | -$127.3M | -$148.3M | -$192.3M | -$141.5M | -$112.5M |
| Free cash flow | -$66.0M | -$127.5M | -$148.5M | -$192.6M | -$142.1M | -$115.8M |
| Diluted shares | 16.0M | 15.0M | 14.2M | 13.7M | 12.7M | 5.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $182.3M | $228.3M | $372.0M | $538.5M | $746.4M | $941.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | $100.0M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $323.8M | $436.0M | $589.7M | $1.22B | $1.45B | $1.38B |
| Total liabilities | $76.0M | $119.7M | $109.5M | $133.7M | $185.0M | $130.4M |
| Shareholders' equity | $247.8M | $316.2M | $480.2M | $1.08B | $1.26B | $1.25B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology